Alps Global Holding Berhad is scaling up its regional biotech footprint with new preclinical trials in stem cell therapy, a strategic Alzheimer’s research collaboration, and preparations for its upcoming Nasdaq IPO.

Watch this update to learn how Alps is driving forward regenerative medicine, cellular immunotherapy, and cross-border R&D partnerships in Asia.